Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 04, 2023 17:00 ET | Source: Iterum Therapeutics PLC

Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023

DUBLIN, Ireland and CHICAGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation...
June 12, 2023 18:23 ET | Source: Iterum Therapeutics PLC

Iterum Therapeutics to Present Data at ASM Microbe 2023

DUBLIN, Ireland and CHICAGO, June 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation...
May 12, 2023 07:00 ET | Source: Iterum Therapeutics PLC

Iterum Therapeutics Reports First Quarter 2023 Financial Results

--Registration Trial for uUTI Ongoing and On Track-- --Cash Runway until Mid-2024-- DUBLIN, Ireland and CHICAGO, May 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum),...
April 20, 2023 17:00 ET | Source: Iterum Therapeutics PLC

Iterum Therapeutics Presents Scientific Posters at ECCMID 2023 Highlighting Application of Desirability of Outcomes Ranking (DOOR) to two Registration Trials

DUBLIN, Ireland and CHICAGO, April 20, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation...
March 16, 2023 07:00 ET | Source: Iterum Therapeutics PLC

Iterum Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

--Registration Trial for uUTI Ongoing and On Track----Cash Runway until Mid-2024-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, March 16, 2023 (GLOBE...
March 09, 2023 17:00 ET | Source: Iterum Therapeutics PLC

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023

DUBLIN, Ireland and CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation...
January 11, 2023 18:00 ET | Source: Iterum Therapeutics plc

Iterum Therapeutics Reports Employment Inducement Grant

DUBLIN, Ireland and CHICAGO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum Therapeutics”), a clinical-stage pharmaceutical company focused on developing next...
December 15, 2022 08:00 ET | Source: Iterum Therapeutics plc

Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem

DUBLIN, Ireland and CHICAGO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a clinical-stage pharmaceutical company focused on developing next...
November 10, 2022 07:00 ET | Source: Iterum Therapeutics plc

Iterum Therapeutics Reports Third Quarter 2022 Financial Results

--Patient Enrollment in Registration Trial for uUTI Underway-- --Cash Runway into 2024-- DUBLIN, Ireland and CHICAGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM)...
November 03, 2022 08:00 ET | Source: Iterum Therapeutics plc

Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022

DUBLIN, Ireland and CHICAGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation...